Clinical Research Directory
Browse clinical research sites, groups, and studies.
BAL Fluid Biomarkers in Sarcoma
Sponsor: University Health Network, Toronto
Summary
This is a single-centre, Phase II, prospective study designed to assess BALF and TA-derived biomarkers in relation to metastatic burden in STS patients. BALF and TA samples will be collected during routine bronchoscopy performed as part of standard care at Toronto General Hospital (TGH). Additionally, tissue samples of lung metastases and adjacent normal lung will be collected and used to correlate the identified biomarkers.
Official title: Prospective Study of Biomarkers Derived From Bronchoalveolar Lavage Fluid to Predict Outcomes in Soft-Tissue Sarcomas
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2025-01-29
Completion Date
2032-04-01
Last Updated
2026-03-04
Healthy Volunteers
No
Interventions
Bronchoscopy & Metastasectomy
Routine bronchoscopy and standard of care metastasectomy
Locations (1)
Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network
Toronto, Ontario, Canada